子宫动脉结扎术在腹腔镜下子宫肌瘤挖除术中的应用价值  被引量:3

Application valuation of uterine artery ligation in laparoscopic myomectomy

在线阅读下载全文

作  者:王海英[1] 

机构地区:[1]成都市第五人民医院妇产科, 611130

出  处:《中国医师进修杂志》2014年第9期22-24,共3页Chinese Journal of Postgraduates of Medicine

摘  要:目的 探讨子宫动脉结扎术(UAL)在腹腔镜下子宫肌瘤挖除术中的应用价值.方法 选择行腹腔镜下子宫肌瘤挖除术治疗的子宫肌瘤患者75例,按随机数字表法分为两组,其中试验组33例,行腹腔镜下子宫肌瘤挖除术前先行UAL;对照组42例,直接行腹腔镜下子宫肌瘤挖除术,对两组患者的预后及术后复发率进行比较.结果 试验组手术时间、术中出血量、住院时间、中转开腹率、术后残腔血肿形成率、症状改善率及复发率均优于对照组[(42.46±37.22) min比(73.23±48.82) min、(143.12±81.46) ml比(214.70±149.19) ml、(5.17±1.08)d比(9.21±1.20)d、12.1%(4/33)比28.6% (12/42)、18.2% (6/33)比31.0%(13/42)、93.9%(31/33)比81.0% (34/42)、12.1%(4/33)比23.8%(10/42)],差异有统计学意义(P<0.05).结论 UAL在行腹腔镜下子宫肌瘤挖除术中安全有效,可明显减少手术时间及术中出血量,并能有效降低住院时间、中转开腹率及术后残腔血肿形成率.Objeetive To analyze the application valuation of uterine artery ligation in laparoscopic myomectomy.Methods Seventy-five hysteromyoma patients who underwent laparoscopic myomectomy were collected.The patients were divided into 2 groups by random digits table method,33 cases underwent uterine artery ligation before laparoscopic myomectomy (experiment group),and 42 cases only received laparoscopic myomectomy (control group).The prognosis and postoperative recurrence rate were compared between the 2 groups.Results The duration of operation,amount of bleeding,length of stay,laparotomy rate,postoperative residual cavity hematoma formation rate,improving rate and recurrence rate in experiment group were better than those in control group [(42.46 ±37.22) min vs.(73.23 ±48.82) min,(143.12 ±81.46) ml vs.(214.70 ± 149.19) ml,(5.17 ± 1.08) d vs.(9.21 ± 1.20) d,12.1%(4/33) vs.28.6%(12/42),18.2%(6/33) vs.31.0% (13/42),93.9% (31/33) vs.81.0% (34/42),12.1% (4/33) vs.23.8% (10/42)],there were statistical differences (P 〈 0.05).Conclusions Uterine artery ligation in laparoscopic myomectomy is safe and effective.It can decrease the duration of operation,amount of bleeding,length of stay,laparotomy rate and postoperative residual cavity hematoma formation rate.

关 键 词:平滑肌瘤 腹腔镜 子宫动脉结扎术 子宫肌瘤挖除术 

分 类 号:R737.33[医药卫生—肿瘤]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象